A Randomized Non-Inferiority Study Comparing Imipenem/cilastatin/relebactam with Standard-of-care Gram-negative Coverage in Cancer Patients with Febrile Neutropenia.
Journal of Antimicrobial Chemotherapy（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined